Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro

Erstveröffentlichung
2023Authors
Arrow, Sebastian S.
Felis, Simone C.
Hillenmayer, Anna
Strehle, Laura D.
Koenig, Susanna F.
Wissenschaftlicher Artikel
Published in
Biomedicine & Pharmacotherapy ; 158 (2023). - Art.-Nr. 114088. - ISSN 0753-3322. - eISSN 1950-6007
Link to publication
https://dx.doi.org/10.1016/j.biopha.2022.114088Institutions
UKU. Klinik für AugenheilkundeSubject headings
[Free subject headings]: Proliferative vitreretinopathy | Retinal detachment | Slow -release drug carrier | Methotrexate | Polylactide-co-glycolide | Orphan drug | DEXAMETHASONE INTRAVITREAL IMPLANT | INTRAOCULAR METHOTREXATE | BIOMEDICAL APPLICATIONS | DELIVERY-SYSTEMS | MACULAR EDEMA | PLGA | TOXICITY | UVEITIS[DDC subject group]: DDC 610 / Medicine & health